Skip to main content
Premium Trial:

Request an Annual Quote

Relax, Bill. It's Larry's Day to Hear Complaints

Over at Omics! Omics!, Keith Robison has a bone to pick with Larry Ellison. He offers up the post as a balance to his anti-Microsoft complaints, so this one is aimed at "the other software giant I rely on but also frequently complain about: Oracle," he writes. The relational database tool could be improved by more consistent syntax and error messages that are actually helpful, according to Robison. He concludes: "Larry probably has bigger fish to fry. Personally, though, if it was my software I'd be cringing."

 

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.